BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
sai life sciences limited stock

Sai Life Sciences Limited Share Price

662.2 -17.64 (-2.59%)
14 Feb 2025 | 03:30 PM Pharmaceuticals NSE: SAILIFE

Sai Life Sciences Limited Share Price Update

As of the latest trading session, Sai Life Sciences Limited share price is currently at 662.2, which is down by -17.64 from its previous closing. Today, the stock has fluctuated between 639.15 and 689.60. Over the past year, Sai Life Sciences Limited has achieved a return of 0.00 %. In the last month alone, the return has been -9.16 %. Read More...

Sai Life Sciences Limited Performance

Day Range

Low639.15 High689.60
662.20

52 Week Range

Low 645.00 High 808.80
662.20

Sai Life Sciences Limited Share Price

27839

544306

SAILIFE

img img img img
No Data Available

Open Price

689.60

Prev. Close

679.85

Volume (Shares)

288841.00

Total traded value

1912.70

Upper Circuit

815.80

Lower Circuit

543.90

Note: The current prices & values are delayed, Login to your account for live updates.

Sai Life Sciences Limited Fundamentals


(Standalone)

Market Cap (Cr) 1169.64
PE Ratio (TTM) 94.77
Book Value / Share 94.34
Beta 1.56
ROE 9.90%
EPS (TTM) 6.97
Dividend Yield 0.00%
Net Profit Qtr (Cr) 51.06

Sai Life Sciences Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 428.60
Operating Expense 370.14
Net Profit 51.06
Net Profit Margin (%) 11.91
Earnings Per Share (EPS) 2.74
EBITDA 120.63
Effective Tax Rate (%) 24.82
Particulars SEP 2024 (Values in Cr)
Revenue 381.97
Operating Expense 333.43
Net Profit 43.85
Net Profit Margin (%) 11.47
Earnings Per Share (EPS) 2.32
EBITDA 110.72
Effective Tax Rate (%) 25.04
Particulars JUN 2024 (Values in Cr)
Revenue 264.47
Operating Expense 0.00
Net Profit -11.38
Net Profit Margin (%) -4.30
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 427.54
Operating Expense 0.00
Net Profit 61.50
Net Profit Margin (%) 14.38
Earnings Per Share (EPS) 34.07
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 372.60
Operating Expense 329.08
Net Profit 40.18
Net Profit Margin (%) 10.78
Earnings Per Share (EPS) 22.27
EBITDA 104.11
Effective Tax Rate (%) 25.77
Particulars MAR 2024 (Values in Cr)
Revenue 1418.68
Operating Expense 1319.01
Net Profit 95.23
Net Profit Margin (%) 6.71
Earnings Per Share (EPS) 52.57
EBITDA 315.94
Effective Tax Rate (%) 26.17
Particulars MAR 2023 (Values in Cr)
Revenue 1157.40
Operating Expense 1152.68
Net Profit 24.24
Net Profit Margin (%) 2.09
Earnings Per Share (EPS) 14.26
EBITDA 191.10
Effective Tax Rate (%) 25.84
Particulars MAR 2022 (Values in Cr)
Revenue 841.02
Operating Expense 846.82
Net Profit 15.68
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 10.12
EBITDA 149.54
Effective Tax Rate (%) 29.84
Particulars MAR 2021 (Values in Cr)
Revenue 751.47
Operating Expense 691.17
Net Profit 65.30
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 39.11
EBITDA 188.69
Effective Tax Rate (%) 25.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 551.96
ROE % 8.89
ROCE % 10.46
Total Debt to Total Equity 1.00
EBITDA Margin 21.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 503.80
ROE % 1.13
ROCE % 5.29
Total Debt to Total Equity 0.95
EBITDA Margin 16.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 500.21
ROE % -0.58
ROCE % 3.12
Total Debt to Total Equity 0.80
EBITDA Margin 16.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 494.88
ROE % 7.37
ROCE % 8.55
Total Debt to Total Equity 0.57
EBITDA Margin 25.61
Particulars MAR 2020 (Values in Cr)
Book Value / Share 484.03
ROE % 9.61
ROCE % 11.42
Total Debt to Total Equity 0.38
EBITDA Margin 25.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 572.37
ROE % 9.90
ROCE % 11.36
Total Debt to Total Equity 0.90
EBITDA Margin 22.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 517.79
ROE % 2.69
ROCE % 5.96
Total Debt to Total Equity 0.90
EBITDA Margin 16.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 507.50
ROE % 0.50
ROCE % 3.72
Total Debt to Total Equity 0.79
EBITDA Margin 16.85
Particulars MAR 2021 (Values in Cr)
Book Value / Share 486.92
ROE % 7.86
ROCE % 8.93
Total Debt to Total Equity 0.57
EBITDA Margin 25.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 484.05
ROE % 10.61
ROCE % 12.57
Total Debt to Total Equity 0.37
EBITDA Margin 25.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 158.80
Total Assets 2275.13
Total Liabilities 2275.13
Total Equity 975.14
Share Outstanding 17663034
Price to Book Ratio 0.00
Return on Assets (%) 3.63
Return on Capital (%) 4.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 86.33
Total Assets 2186.64
Total Liabilities 2186.64
Total Equity 888.09
Share Outstanding 17622556
Price to Book Ratio 0.00
Return on Assets (%) 0.45
Return on Capital (%) 0.63
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 152.00
Total Assets 2239.92
Total Liabilities 2239.92
Total Equity 1011.19
Share Outstanding 17663034
Price to Book Ratio 0.00
Return on Assets (%) 4.25
Return on Capital (%) 5.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.01
Total Assets 2130.62
Total Liabilities 2130.62
Total Equity 912.73
Share Outstanding 17622556
Price to Book Ratio 0.00
Return on Assets (%) 1.13
Return on Capital (%) 1.5
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 123.52
Total Assets 2105.89
Total Liabilities 2105.89
Total Equity 891.03
Share Outstanding 17556306
Price to Book Ratio 0.00
Return on Assets (%) 0.74
Return on Capital (%) 0.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 70.09
Total Assets 1816.48
Total Liabilities 1816.48
Total Equity 867.51
Share Outstanding 17429579
Price to Book Ratio 0.00
Return on Assets (%) 3.59
Return on Capital (%) 4.34
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 92.96
Total Assets 1389.22
Total Liabilities 1389.22
Total Equity 794.41
Share Outstanding 16382929
Price to Book Ratio 0.00
Return on Assets (%) 5.76
Return on Capital (%) 7.45
Particulars MAR 2024 (Values in Cr)
Net Income 109.23
Cash from Operations 276.96
Cash from Investing -192.38
Cash from Financing -95.29
Net change in Cash -24.59
Free Cash Flow 458.65
Particulars MAR 2023 (Values in Cr)
Net Income 16.40
Cash from Operations 223.48
Cash from Investing -101.78
Cash from Financing -200.64
Net change in Cash -83.02
Free Cash Flow 336.55
Particulars MAR 2022 (Values in Cr)
Net Income 9.69
Cash from Operations 112.98
Cash from Investing -103.71
Cash from Financing 71.92
Net change in Cash 75.15
Free Cash Flow 319.90
Particulars MAR 2021 (Values in Cr)
Net Income 81.91
Cash from Operations -20.93
Cash from Investing -259.89
Cash from Financing 295.49
Net change in Cash -0.77
Free Cash Flow 241.13
Particulars MAR 2020 (Values in Cr)
Net Income 109.08
Cash from Operations 135.13
Cash from Investing -261.69
Cash from Financing -4.06
Net change in Cash -150.25
Free Cash Flow 407.29
Particulars MAR 2024 (Values in Cr)
Net Income 129.00
Cash from Operations 264.13
Cash from Investing -190.05
Cash from Financing -84.63
Net change in Cash -24.03
Free Cash Flow 443.49
Particulars MAR 2023 (Values in Cr)
Net Income 32.68
Cash from Operations 225.55
Cash from Investing -111.22
Cash from Financing -190.04
Net change in Cash -79.79
Free Cash Flow 339.53
Particulars MAR 2022 (Values in Cr)
Net Income 22.35
Cash from Operations 96.48
Cash from Investing -94.63
Cash from Financing 80.95
Net change in Cash 74.69
Free Cash Flow 294.31
Particulars MAR 2021 (Values in Cr)
Net Income 87.58
Cash from Operations -9.23
Cash from Investing -279.45
Cash from Financing 303.57
Net change in Cash -1.81
Free Cash Flow 231.82
Particulars MAR 2020 (Values in Cr)
Net Income 114.08
Cash from Operations 128.13
Cash from Investing -259.40
Cash from Financing -1.40
Net change in Cash -152.04
Free Cash Flow 375.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 27.82 2.64 370.98 39.20 / 77.70
BLISS GVS PHARMA LTD 132.25 17.33 1.37 1393.52 92.25 / 184.95
CIPLA LTD 1459.05 23.62 4.15 117834.93 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 298.95 24.77 3.03 879.84 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 42.10 8.23 370.98 39.20 / 77.70
AMRUTAJAN HEALTH LTD 612.45 35.90 5.94 1770.63 591.10 / 861.40
ASTRAZENECA PHARMA IND LT 7096.35 105.84 26.11 17740.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 132.25 17.18 1.36 1393.52 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 681.10
  • 26 Days 698.00
  • 10 Days 687.40
  • 50 Days 711.70
  • 12 Days 688.50
  • 100 Days 711.70
  • 20 Days 693.30
  • 200 Days 711.70
685.07
PIVOT
First Resistance 694.33
Second Resistance 708.82
Third Resistance 718.08
First Support 670.58
Second Support 661.32
Third Support 646.83
RSI 41.11
MACD -9.50
Commodity Channel Index (CCI) -76.46
ADX 18.86
Williams % R -81.68

Over 1 Month

down

-9.16

Over 3 Months

down

-13.39

Over 6 Months

down

0.00

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

Sai Life Sciences Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Sai Life Sciences Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
41.09
Promoter Holdings
35.23
FII
11.71
DII
11.94
Promoter Shares(Pledge Percentage)
2.67
Name Category Shares Shares%
Tpg Asia Vii Sf Pte Ltd Public Shareholding 5.1548272E7 24.78
Mytreyi Kanumuri Shareholding of Promoter and Promoter Group 2.218555E7 10.67
Ranga Raju Kanumuri Shareholding of Promoter and Promoter Group 1.559357E7 7.5
Gokaraju Subba Raju Shareholding of Promoter and Promoter Group 9634450.0 4.63
Mytreyi Kanumuri Shareholding of Promoter and Promoter Group 9282060.0 4.46
Ranga Raju Kanumuri Shareholding of Promoter and Promoter Group 6900740.0 3.32
Sai Quest Syn Private Limited Shareholding of Promoter and Promoter Group 4591100.0 2.21
Invesco India Midcap Fund Public Shareholding 4543060.0 2.18
Hbm Private Equity India Public Shareholding 4140124.0 1.99
Nippon Life India Trustee Ltd-a/c Nippon India Pha Public Shareholding 4047623.0 1.95
Anitha Rudraraju Nandyala Public Shareholding 3602370.0 1.73
Krishnam Raju Kanumuri Shareholding of Promoter and Promoter Group 3008400.0 1.45
Smallcap World Fund, Inc Public Shareholding 2817728.0 1.35
Goldman Sachs Funds - Goldman Sachs India Equity P Public Shareholding 2769405.0 1.33
Hsbc Aggressive Hybrid Fund Public Shareholding 2606870.0 1.25
Raju Penmasta Public Shareholding 2309800.0 1.11
Penmasta Aruna Public Shareholding 2121220.0 1.02
Tanuja Gokaraju Shareholding of Promoter and Promoter Group 1334535.0 0.64
Sudha Kanumuri Shareholding of Promoter and Promoter Group 513160.0 0.25
Ranga Raju Kanumuri Shareholding of Promoter and Promoter Group 169340.0 0.08
Mytreyi Kanumuri Shareholding of Promoter and Promoter Group 61580.0 0.03
Continental Wines P Ltd Shareholding of Promoter and Promoter Group 20190.0 0.01

Sai Life Sciences Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Sai Life Sciences Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Sai Life Sciences Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sai Life Sciences Ltd?

Answer Field

The share price of Sai Life Sciences Ltd for NSE is ₹ 662.2 and for BSE is ₹ 668.4.

What is the Market Cap of Sai Life Sciences Ltd?

Answer Field

The market cap of Sai Life Sciences Ltd for NSE is ₹ 11,69.64 Cr. and for BSE is ₹ 11,80.59 Cr. as of now.

What is the 52 Week High and Low of Sai Life Sciences Ltd?

Answer Field

The 52 Week High and Low of Sai Life Sciences Ltd for NSE is ₹ 808.80 and ₹ 639.15 and for BSE is ₹ 808.20 and ₹ 639.60.

How to Buy Sai Life Sciences Ltd share?

Answer Field

You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sai Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Sai Life Sciences Ltd?

Answer Field

Sai Life Sciences Ltd share price is for NSE ₹ 662.2 & for BSE ₹ 668.4 as on 14 Feb 2025 | 03:30 PM.

What is the Market Cap of Sai Life Sciences Ltd Share?

Answer Field

The market cap of Sai Life Sciences Ltd for NSE ₹ 11,69.64 & for BSE ₹ 11,80.59 as on 14 Feb 2025 | 03:30 PM.

What is the P/E Ratio of Sai Life Sciences Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM the price-to-earnings (PE) ratio for Sai Life Sciences Ltd share is 94.77.

What is the PB ratio of Sai Life Sciences Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM, the price-to-book (PB) ratio for Sai Life Sciences Ltd share is 94.34.

How to Buy Sai Life Sciences Ltd Share?

Answer Field

You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sai Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Sai Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sai Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader